Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.15
+0.25 (3.23%)
At close: May 29, 2025, 4:00 PM
7.75
-0.39 (-4.85%)
After-hours: May 29, 2025, 6:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Bioresorbable Hydrogel-based Formulation Technology
63.46M
Log In
Log In
Log In
Log In
Upgrade
Bioresorbable Hydrogel-based Formulation Technology Growth
9.66%
Log In
Log In
Log In
Log In
Upgrade
Collaboration
262.00K
Log In
Log In
Log In
Log In
Upgrade
Collaboration Growth
-54.28%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
63.72M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.03%
Log In
Log In
Log In
Log In
Upgrade